TITLE

SINDROM MASQUERADE ÅžI MELANOMUL MALIGN CUTANAT ACROMIC -- CAZ CLINIC

PUB. DATE
July 2010
SOURCE
Jurnalul de Chirurgie;2010, Vol. 6 Issue 3, p333
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
56642059

 

Related Articles

  • Commentary: Ultrasonography of ocular tumors. Bhatt, Deepak // Indian Journal of Radiology & Imaging;Feb2007, Vol. 17 Issue 1, p15 

    The article focuses on the use of ultrasonography (USG) in diagnosing ocular tumors. It mentions the two types of ocular tumors, namely retinoblastoma which is seen in children and choroidal melanomas which is seen in adults. According to the author, USG is an excellent tool for follow-up while...

  • Cytomegalovirus Infection Global Clinical Trials Review, Q1 2011.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p677 

    The article focuses on the "Cytomegalovirus Infection Global Clinical Trials Review, Q1 2011" report from GlobalData.

  • New CMV retinitis drug can be taken less often. McCann, Jean // Drug Topics;7/22/96, Vol. 140 Issue 14, p20 

    Cites the potential of the Vistide, generically known as cidofovir and made by Gilead Sciences Inc., in treating cytomegalovirus retinitis, the dreaded complication of AIDS leading to blindness. Approval received from the United States Food and Drug Administration; Advantage of the cidofovir...

  • Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC peripheral...  // Annals of Internal Medicine;02/15/97, Vol. 126 Issue 4, p264 

    Presents the results of a study evaluating intravenous cidofovir as a treatment for cytomegalovirus retinitis. Evaluation of disease progression in a masked manner by a fundus photograph reading center; Administration of probenecid and hydration to prevent nephrotoxicity; Efficacy of the drug...

  • Folate and heart disease: Theoretical link needs study. Levin, Aaron // Annals of Internal Medicine;02/15/97, Vol. 126 Issue 4, pI-59 

    No abstract available.

  • GENTA STARTS PHASE 3 AGENDA TRIAL OF GENASENSE FOR MELANOMA.  // Biotech Business;Oct2007, Vol. 20 Issue 10, p3 

    The article reports that Genta Inc. had its first patients enrolled in its confirmatory Phase 3 trial of Genasense Injection in advanced melanoma. The trial known as AGENDA, will accrue approximately 300 patients and will be conducted at approximately 100 sites worldwide. The trial is designed...

  • Alternative Possible for Advanced Melanoma. Nemec, John // Dermatology Times;Mar2000, Vol. 21 Issue 3, p12 

    Focuses on a study by doctor Mark Middleton and colleagues, which suggests that oral temozolomide can be as effective as intravenous dacarbazine in treating patients with advanced metastatic melanoma. Results of an international phase III clinical trial; Quality-of-life evaluation; Combination...

  • How to get under a cancer's skin. Tuma, Rabiya // New Scientist;04/15/2000, Vol. 166 Issue 2234, p16 

    Reports that use of a DNA spanner may make melanoma vulnerable to chemotherapy. Trials of the drug G3139; Reason for melanoma's resistance to chemotherapy; Plans for a large-scale clinical trial.

  • Options expanding in management of ocular tumors. Charters, Lynda; Shields, Jerry // Ophthalmology Times;02/01/2000, Vol. 25 Issue 3, p24 

    Discusses options in the management of ocular tumors. Information on chemothermotherapy; Details on transpupillary thermotherapy; Combination of the treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics